Follow the Solara Active Pharma Sciences Limited stock price and the full management transaction log of the company, a publicly traded company based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Solara Active Pharma Sciences Limited has recorded 128 public disclosures. Market capitalisation: €24.5bn. The latest transaction was disclosed on 30 June 2025 (Sale). Among the most active insiders: PRONOMZ VENTURES LLP. Every trade is free.
128
Insider Decl.
n/a
Thresholds
€32m
54 ops.
Buy Volume
€33m
37 ops.
Sell Volume
10Σ signal
Buys €32m€33m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,102 of 29,062 companies
39.0
score / 100
Value
41
Quality
37
FCF yld4.1%
Earn yld-0.3%
EV/EBITDA16.8x
ROE-0.6%
Gross mgn50%
Net mgn-0.5%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
13,625 shares@ ₹371.352665.5% of flowEquity SharesSEBI:df2a50d042518004dbe1f1362b3e63af0efab4c7
25 of 128 declarations
Acerca de Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited es una empresa centrada en la fabricación de productos farmacéuticos. Opera en el mercado XBOM y se especializa en el desarrollo de soluciones activas para la industria de la salud.